Nitrofurantoin
Average across 6 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Amneal Pharmaceuticals LLC | unknown | 2 | SUPPLYING |
| Rising Pharma Holdings, Inc. | unknown | 2 | SUPPLYING |
| Camber Pharmaceuticals, Inc. | unknown | 1 | SUPPLYING |
| Novel Laboratories, Inc. | unknown | 1 | SUPPLYING |
| Lupin Pharmaceuticals, Inc. | unknown | 1 | SUPPLYING |
| ANI Pharmaceuticals, Inc. | unknown | 1 | SUPPLYING |
| NorthStar Rx LLC | unknown | 1 | SUPPLYING |
| Biocon Pharma Inc, | unknown | 1 | SUPPLYING |
| Aurobindo Pharma Limited | unknown | 1 | SUPPLYING |
Shortages, recalls, and registration changes attached to this drug concept.
Nitrofurantoin Oral Suspension — reported in shortage by Amneal Pharmaceuticals. Therapeutic category: Anti-Infective, Other.
Nitrofurantoin Oral Suspension — reported in shortage by Amneal Pharmaceuticals. Therapeutic category: Anti-Infective, Other.
Subpotent Drug: Expansion of June 2018 recall of lots S700065 and S700619 due to below specification results for assay. — Recalling firm: LUPIN SOMERSET — Nationwide in the USA and Puerto Rico.
Subpotent Drug and Failed Content Uniformity. — Recalling firm: LUPIN SOMERSET — Nationwide within the US
Pill